Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease

被引：63
|
作者：
Carpentier, AF [1 ]
Bonnet, AM [1 ]
Vidailhet, M [1 ]
Agid, Y [1 ]
机构：
[1] FED NEUROL, PARIS, FRANCE
来源：
NEUROLOGY | 1996年 / 46卷 / 06期
关键词：
D O I：
10.1212/WNL.46.6.1548
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Seven patients suffering from Parkinson's disease (PD) with severely disabling dyskinesia received low-dose propranolol as an adjunct to the currently used medical treatment. There was a significant 40% improvement in the dyskinesia. score without increase of parkinsonian motor disability. Ballistic and choreic dyskinesia were markedly ameliorated, whereas dystonia was not. This study suggests that administration of low doses of beta-blockers may improve levodopa-induced ballistic and choreic dyskinesia in PD.
引用
收藏
页码：1548 / 1551
页数：4
相关论文
共 50 条
  • [31] Levodopa-induced dyskinesia in Parkinson's disease: Epidemiology, etiology, and treatment
    Zesiewicz, Theresa A.
    Sullivan, Kelly L.
    Hauser, Robert A.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2007, 7 (04) : 302 - 310
  • [32] Pathophysiology of levodopa-induced dyskinesia in Parkinson's disease: A TMS study
    Morgante, F
    Espay, AJ
    Gunraj, C
    Lang, AE
    Chen, R
    MOVEMENT DISORDERS, 2005, 20 (09) : 1238 - 1238
  • [33] Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease
    Santos-Lobato, Bruno Lopes
    Schumacher-Schuh, Artur F.
    Rieder, Carlos R. M.
    Hutz, Mara H.
    Borges, Vanderci
    Ferraz, Henrique Ballalai
    Mata, Ignacio F.
    Zabetian, Cyrus P.
    Tumas, Vitor
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2020, 78 (04) : 206 - 216
  • [34] Chemical management of levodopa-induced dyskinesia in Parkinson's disease patients
    Dragasevic-Miskovic, Natasa
    Petrovic, Igor
    Stankovic, Iva
    Kostic, Vladimir S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 219 - 230
  • [35] A Web Resource for Levodopa-Induced Dyskinesia Genetics in Parkinson’s Disease
    Hagen Blankenburg
    Marika Falla
    Christine Schwienbacher
    Giovanni Fabbrini
    Alfredo Berardelli
    Peter P. Pramstaller
    Francisco S. Domingues
    Neuroinformatics, 2017, 15 : 297 - 300
  • [36] Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia
    Su, Dongning
    Gan, Yawen
    Zhang, Zhe
    Cui, Yusha
    Zhang, Zhijin
    Liu, Zhu
    Wang, Zhan
    Zhou, Junhong
    Sossi, Vesna
    Stoessl, A. Jon
    Wu, Tao
    Jing, Jing
    Feng, Tao
    MOVEMENT DISORDERS, 2023, 38 (04) : 616 - 625
  • [37] Assessment of Parkinson’s disease levodopa-induced dyskinesia: a qualitative research study
    William R. Lenderking
    Sally Mannix
    Jennifer Petrillo
    Christopher Kenney
    Amanda Landrian
    Anette-Eleonore Schrag
    Quality of Life Research, 2015, 24 : 1899 - 1910
  • [38] Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: A pilot study
    Sieradzan, KA
    Fox, SH
    Hill, M
    Dick, JPR
    Crossman, AR
    Brotchie, JM
    NEUROLOGY, 2001, 57 (11) : 2108 - 2111
  • [39] Investigation of PRKN Mutations in Levodopa-Induced Dyskinesia in Parkinson's Disease Treatment
    Bispo, Ana Gabrielle
    Silva, Caio S.
    Sena-dos-Santos, Camille
    Moura, Dafne Dalledone
    Koshimoto, Brenda Hanae Bentes
    Santos-Lobato, Bruno Lopes
    Ribeiro-dos-Santos, Andrea
    Cavalcante, Giovanna C.
    BIOMEDICINES, 2023, 11 (08)
  • [40] Prominent Oromandibular Dystonia as Levodopa-induced Dyskinesia in Idiopathic Parkinson's Disease
    Tee, Tze Yuan
    Khoo, Ching Soong
    Norlinah, Mohamed Ibrahim
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (04): : 330 - 331
12345